Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation

BACKGROUND: To evaluate the impact of targeted agents in stage II-III rectal cancer undergoing neoadjuvant concurrent chemoradiation therapy (CCRT). METHOD: A retrospective study was performed in 124 consecutive patients with clinically T(3)N(0-2)M(0)-staged rectal cancer incorporating targeted agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jin-Tung, Chen, Tzu-Chun, Huang, John, Jeng, Yung-Ming, Cheng, Jason Chia-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731917/
https://www.ncbi.nlm.nih.gov/pubmed/29254207
http://dx.doi.org/10.18632/oncotarget.21762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731917/
https://www.ncbi.nlm.nih.gov/pubmed/29254207
http://dx.doi.org/10.18632/oncotarget.21762

Ejemplares similares